GL1X · GenesisL1 explorer

MolNFT v1 · #108616 · protein

Catalytic domain of mouse 2',3'-cyclic nucleotide 3'- phosphodiesterase, with mutation P225G

4WCC · 2',3'-cyclic-nucleotide 3'-phosphodiesterase: “Catalytic domain of mouse 2',3'-cyclic nucleotide 3'- phosphodiesterase, with mutation P225G”. X-ray diffraction, 2 ligands (2AM, CL), 1 pocket (best druggability 0.57). MolNFT v1…

PDB
4WCC
Type
protein
Length
205 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
2',3'-cyclic-nucleotide 3'-phosphodiesterase
EC
3.1.4.37
UniProt
P16330
Ligands
2AM, CL
Pockets
1 · best druggability 0.57

Structure

x-ray diffraction · 1 distinct chain · 29% helix, 33% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A2',3'-cyclic-nucleotide 3'-phosphodiesterase (EC 3.1.4.37)protein20529% helix, 33% strandP16330

Ligands and binding sites

  • 2AM · Adenosine-2'-monophosphate · ligand · chains A
  • CL · Chloride ion · ion · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12860.570.77392AM, CL

Compared structures

  • 4WCC · Catalytic domain of mouse 2',3'-cyclic nucleotide 3'- phosphodiesterase, with mutation… · the same entry in another collection · chain A against A, TM-score 1.00
  • P16330 · AlphaFold monomer V2.0 prediction for 2',3'-cyclic-nucleotide 3'-phosphodiesterase… · a predicted model of the same protein · chain A against A, TM-score 0.97

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.